10 Dec 2018 Avacta and LG Chem Life Sciences agree multi-target Affimer® therapeutics development alliance Investors | Therapeutics
12 Nov 2018 Avacta’s Chief Scientific Officer to Present Recent Data at Major European Conference Investors | Therapeutics
11 Oct 2018 Avacta’s Chief Technology Officer to Present at Major US Conference Investors | Reagents & Diagnostics
10 Oct 2018 Avacta agrees Affimer reagent licensing deal with New England Biolabs (NEB) Investors | Reagents & Diagnostics